Upcoming Events

American Association for Cancer Research Annual Meeting

Title: Next generation capecitabine (NGC-Cap) in phase 1b trial significantly increases 5-FU exposure while improving safety profile compared to capecitabine
Session Title: First-in-Human Phase I Clinical Trials 1
Session Date and Time: Monday, April 8, 2024 - 1:30 PM - 5:00 PM
Location: 
Poster Section 48
Poster Number: 11

Title: Application of phase 1 and pre-clinical data to assist in determining the optimal dosage regimen for cancer drugs using the principles of Project Optimus
Session Title: Late-Breaking Research: Experimental and Molecular Therapeutics 3
Session Date and Time: Tuesday, April 9, 2024 - 9:00 AM - 12:30 PM
Location: Poster Section 52
Poster Number: 23

Past Events

2024 BIO CEO & Investor Conference

Special Meeting of Stockholders

View All Past Events